Vaginal Fungi Infections Treatment Market, by Drug Type (Fluconazole, Nystatin, Flucytosine and Others), by Route of Administration (Oral and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Nov 2020

Code : CMI4271

Pages :185

Formats :

Excel and PDF

Industry : Pharmaceutical

Vaginal Fungi Infections Treatment MarketSize and Trends

The global vaginal fungi infections treatment market is estimated to be valued at US$ 987.2 million in 2020 and is expected to exhibit a CAGR of 5.3% during the forecast period (2020-2027).

The increasing product launches is expected to propel growth of the global vaginal fungi infections treatment market

Major players in the market are focused on product launches in the market, which is expected to boost the market growth over the forecast period. For instance, in December 2016, Dr. Reddy’s Laboratories Ltd. launched Nystatin and Triamcinolone Acetonide Cream, USP, approved by the U.S. Food & Drug Administration (U.S. FDA).in the U.S. Nystatin and Triamcinolone Acetonide Cream, USP are the generic equivalent of Nystatin and Triamcinolone Acetonide Cream, USP 100,000 units/g- 0.1% manufactured by Taro Pharmaceuticals USA Inc. and these are used to treat fungal or yeast infections of the skin.

Moreover, increasing inorganics strategies such as business expansion adopted by the market players are expected to propel growth of the global vaginal fungi infections treatment market during the forecast period. For instance, in June 2016, Bausch Health Companies Inc. (previously known as Valeant Pharmaceuticals International, Inc.) announced that its subsidiary Valeant Canada is expanding its manufacturing and export capacity in Canada.

Global Vaginal Fungi Infections Treatment Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector which has been impacted significantly by the COVID-19 pandemic.

The lockdown in various countries due to the pandemic has placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products and affected growth of healthcare businesses of various companies across the globe.

As a result, the impact of the COVID-19 pandemic is also expected to limit growth of the global vaginal fungi infections treatment drugs market during the forecast period.

However, the COVID-19 pandemic is also expected to limit growth of the global vaginal fungi infections treatment market during the forecast period. According to the Journal of Clinical Orthopedics and trauma, in May 2020, the coronavirus affects bones and joints of affected patients. As a result, several orthopedic doctors have been deployed for monitoring patients suffering from coronavirus infection. In order to treat such patients, there has been an increase in the manufacture of drugs and research and development.